AXSM three-lens brief
Evidence-based stock research on AXSM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 5.87% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price up 5.87% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 18.7pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $265.86 — 78% above current (21 analysts).
AXSM closed at $149.24 (+5.87%) as of 2026-11-12. Market cap: $7.85B. Price is below the 50-day MA and below the 200-day MA. Positives: price up 5.87% in the last session — a material single-day move.; analyst mean target $265.86 — 78% above current (21 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 18.7pp over 30 days.. Last quarter: Revenue $259.69M, net income -$12.88M, free cash flow -$24.38M.
Why three lenses on AXSM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AXSM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AXSM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AXSM brief"></iframe>